Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2012-08-31
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
early enteral nutrition
Naso-gastro-jejunal tube will be set up by X-ray within 24 hours of admission.
* The distal end of the feeding tube would be placed at the remote end of Treitz ligament, and verified by X-ray.
* After catharsis, Standard enteral nutrition liquid regimen （Peptisorb Liquid）will be used step by step.
* Patients are targeted to receive calories for 25 kcal/kg/day.
early enteral nutrition
Naso-gastro-jejunal tube will be set up by X-ray within 24 hours of admission.
The distal end of the feeding tube would be placed at the remote end of Treitz ligament, and verified by X-ray.
• After catharsis, Standard enteral nutrition liquid regimen will be used step by step.
Patients are targeted to receive calories for 25 kcal/kg/day.
nutrition form: short peptide ,1 kcal/ml,target 200k kcal/day
modified early enteral nutrition
Naso-gastro-jejunal tube will be set up by X-ray within 24 hours of admission.
* The distal end of the feeding tube would be placed at the remote end of Treitz ligament, and verified by X-ray.
* After catharsis, Only Normal Saline were given through Naso-gastro-Jejunal tube until 2 or more followed requirements were met mean arterial pressure≥65mmHg; oxygenation index≥ 300;APCHEII≤8; intra-abdominal pressure \<20mmHg).Then Standard enteral nutrition liquid regimen (Peptisorb Liquid) will be used step by step.
* Patients are targeted to receive calories for 25 kcal/kg/day.
modified early enteral nutrition
Naso-gastro-jejunal tube will be set up by X-ray within 24 hours of admission.
* The distal end of the feeding tube would be placed at the remote end of Treitz ligament, and verified by X-ray.
* After catharsis, Only Normal Saline were given through nasojejunal tube until 2 or more followed requirements were meted (mean arterial pressure≥65mmHg; oxygenation index≥ 300;APCHEII≤8; intra-abdominal pressure \<20mmHg).Then Standard enteral nutrition liquid regimen (Peptisorb Liquid) will be used step by step.
* Patients are targeted to receive calories for 25 kcal/kg/day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
early enteral nutrition
Naso-gastro-jejunal tube will be set up by X-ray within 24 hours of admission.
The distal end of the feeding tube would be placed at the remote end of Treitz ligament, and verified by X-ray.
• After catharsis, Standard enteral nutrition liquid regimen will be used step by step.
Patients are targeted to receive calories for 25 kcal/kg/day.
nutrition form: short peptide ,1 kcal/ml,target 200k kcal/day
modified early enteral nutrition
Naso-gastro-jejunal tube will be set up by X-ray within 24 hours of admission.
* The distal end of the feeding tube would be placed at the remote end of Treitz ligament, and verified by X-ray.
* After catharsis, Only Normal Saline were given through nasojejunal tube until 2 or more followed requirements were meted (mean arterial pressure≥65mmHg; oxygenation index≥ 300;APCHEII≤8; intra-abdominal pressure \<20mmHg).Then Standard enteral nutrition liquid regimen (Peptisorb Liquid) will be used step by step.
* Patients are targeted to receive calories for 25 kcal/kg/day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Onset of abdominal pain within \<=72h before admission
3. moderate severe or severe Acute Pancreatitis according to Atlanta criteria revisited in 2012 ffff
Exclusion Criteria
4. chronic disease of any organ （heart lung gastrointestinal renal etc.） 5. Pre-existing disease with life expectancy \< 3 months 7.receive parenteral nutrition or enteral nutrition before admitting
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
RenJi Hospital
OTHER
Ruijin Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erzhen Chen
Prefessor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Qiang en Mao, phd
Role: STUDY_DIRECTOR
Emergency intensive care unit of Ruijin Hospital
Wen xu, Master
Role: PRINCIPAL_INVESTIGATOR
doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ruijin
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
qiang En mao
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zhen Er Chen, PHD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Ong JP, Fock KM. Nutritional support in acute pancreatitis. J Dig Dis. 2012 Sep;13(9):445-52. doi: 10.1111/j.1751-2980.2012.00611.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RJpancreatitis02
Identifier Type: OTHER
Identifier Source: secondary_id
RJpancreatitis02
Identifier Type: -
Identifier Source: org_study_id